Inhibition of Tumor Angiogenesis by Angiostatin: From Recombinant Protein to Gene Therapy
Endothelium · 2002
DOI: 10.1080/10623320210712 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endothelium, 2002. Verfasst von Raffaella Dell'Eva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, National Cancer Research Institute, Genoa, Italy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 86 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, National Cancer Research Institute, Genoa, Italy.
Zitieren
APA
Dell'Eva, R., Pfeffer, U., Indraccolo, S., Albini, A., & Noonan, D. (2002). Inhibition of Tumor Angiogenesis by Angiostatin: From Recombinant Protein to Gene Therapy. Endothelium. https://doi.org/10.1080/10623320210712
Vancouver
Dell'Eva R, Pfeffer U, Indraccolo S, Albini A, Noonan D. Inhibition of Tumor Angiogenesis by Angiostatin: From Recombinant Protein to Gene Therapy. Endothelium. 2002. doi:10.1080/10623320210712
BibTeX
@article{DellEva2002,
author = {Dell'Eva, Raffaella and Pfeffer, Ulrich and Indraccolo, S and Albini, Adriana and Noonan, Douglas},
title = {Inhibition of Tumor Angiogenesis by Angiostatin: From Recombinant Protein to Gene Therapy},
journal = {Endothelium},
year = {2002},
doi = {10.1080/10623320210712}
}
EUVIMED